Jayson Bedford

Stock Analyst at Raymond James

(3.99)
# 659
Out of 4,333 analysts
194
Total ratings
57.36%
Success rate
8.02%
Average return

22 Stocks

Boston Scientific
Feb 1, 2024
Maintains: Strong Buy
Price Target: $67$73
Current: $67.00
Upside: +8.96%
Merit Medical Systems
Jan 30, 2024
Maintains: Outperform
Price Target: $84$89
Current: $79.81
Upside: +11.51%
Abbott Laboratories
Jan 25, 2024
Maintains: Outperform
Price Target: $124$127
Current: $119.46
Upside: +6.31%
Intuitive Surgical
Jan 25, 2024
Maintains: Outperform
Price Target: $372$435
Current: $389.77
Upside: +11.60%
DexCom
Jan 23, 2024
Maintains: Strong Buy
Price Target: $147$151
Current: $116.26
Upside: +29.88%
AngioDynamics
Jan 9, 2024
Maintains: Outperform
Price Target: $12$10
Current: $5.79
Upside: +72.71%
Zimmer Biomet Holdings
Jan 3, 2024
Maintains: Outperform
Price Target: $133$137
Current: $129.18
Upside: +6.05%
Johnson & Johnson
Jan 3, 2024
Maintains: Outperform
Price Target: $172$175
Current: $161.84
Upside: +8.13%
Becton, Dickinson and Company
Jan 3, 2024
Maintains: Outperform
Price Target: $269$275
Current: $246.20
Upside: +11.70%
Teleflex
Dec 20, 2023
Maintains: Outperform
Price Target: $227$271
Current: $237.75
Upside: +13.99%
BrainsWay
Nov 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $6.03
Upside: -
Masimo
Nov 8, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $132.21
Upside: -
Insulet
Sep 15, 2023
Maintains: Outperform
Price Target: $299$228
Current: $184.21
Upside: +23.77%
Tandem Diabetes Care
Apr 24, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $29.13
Upside: -
Edwards Lifesciences
Feb 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $87.74
Upside: -
Baxter International
Jan 5, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $42.55
Upside: -
ICU Medical
Nov 8, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $103.59
Upside: -
Medtronic
Aug 24, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $85.67
Upside: -
Senseonics Holdings
Mar 5, 2021
Downgrades: Underperform
Price Target: n/a
Current: $0.73
Upside: -
Hologic
Jun 3, 2020
Upgrades: Outperform
Price Target: n/a
Current: $76.15
Upside: -
HeartBeam
Oct 31, 2018
Maintains: Outperform
Price Target: n/a
Current: $1.59
Upside: -
Integra LifeSciences Holdings
Jan 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $44.73
Upside: -